Brief: Valbiotis Publishes Additional Results From Phase IIa Study Of Valedia

Valbiotis SA

02/09/2019 16:49

Sept 2 (Reuters) - Valbiotis SA  ALVAL.PA :
    * ADDITIONAL POSITIVE RESULTS FROM THE PHASE IIA CLINICAL
STUDY OF
VALEDIA
    * RESULTS OF PHASE IIA STUDY HAVE EXCEEDED ALL SET
OBJECTIVES AND
THE OVERALL EFFICACY OF VALEDIA IN SUBJECTS AT RISK OF METABOLIC
DISEASES HAS BEEN PROVEN
    * VALEDIA SIGNIFICANTLY REDUCED BLOOD GLUCOSE LEVELS, AND
BODY
WEIGHT COMPARED TO PLACEBO

Source text for Eikon:  ID:nBw9rL8WRa 
Further company coverage:  ALVAL.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))